The expression of Wnt/β-catenin pathway genes was increased in the xenograft model of primary non-small cell lung cancer (NSCLC), while Wnt/β-catenin pathway genes were significantly down-regulated after anti-HDGF treatment, especially Wnt1 and FZD were severely inhibited. This evidence concerns the gene HDGF and non-small cell lung carcinoma.